Torrent Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Torrent Pharmaceuticals Limited generated cash of $32,660,800,000, which is more than the previous year. Cash used in financing activities reached the amount of -$27,796,400,000 last year. Net change in cash is therefore $3,266,100,000.
Cash Flow
| 2010 | 2.86B | -1.28B | -52.46M |
|---|---|---|---|
| 2011 | 3.94B | -2.32B | -671.36M |
| 2012 | 5.07B | -1.45B | -1.91B |
| 2016 | 27.13B | -7.01B | -14.35B |
| 2018 | 8.94B | -47.06B | 34.17B |
| 2020 | 13.91B | -1.51B | -15.49B |
| 2021 | 20.10B | -4.49B | -16.56B |
| 2023 | 23.68B | -24.15B | 770M |
| 2024 | 32.66B | -1.67B | -27.79B |
TORNTPHARM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.08B | 3.98B | 6.61B | 9.40B | 10.67B | 8.64B | 6.04B | 5.10B | 3.50B |
Operating activities | |||||||||
Net income | 16.56B | 18.47B | 15.26B | 11.86B | 9.31B | 23.63B | 2.84B | 2.70B | 2.31B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 7.95B | 7.07B | 6.57B | 6.54B | 4.08B | 2.46B | 817.29M | 625.58M | 660.86M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 780M | -2.89B | 652.1M | -1.77B | -3.43B | 1.17B | 0 | 0 | 0 |
Inventories | -490M | 2.56B | -5.32B | -2.13B | -3.06B | -2.78B | -267.21M | -1.81B | -590.91M |
Accounts payable | 4.14B | -580.2M | 1.29B | 51.9M | 2.89B | 5.83B | 0 | 0 | 0 |
Cash generated by operating activities | 32.66B | 23.68B | 20.10B | 13.91B | 8.94B | 27.13B | 5.07B | 3.94B | 2.86B |
Investing activities | |||||||||
Purchases Of Investments | 0 | -600M | -1.63B | -39.5M | -272.5M | -1.23B | -175.24M | -9.53M | 0 |
Investments In Property Plant And Equipment | -4.32B | -5.74B | -3.35B | -4.06B | -7.91B | -6.04B | -1.70B | -2.64B | -1.50B |
Acquisitions Net | 0 | -20B | 1.20B | 39.5M | -39.61B | -2.31B | 0 | 0 | 0 |
Cash generated by investing activities | -1.67B | -24.15B | -4.49B | -1.51B | -47.06B | -7.01B | -1.45B | -2.32B | -1.28B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -10.15B | -8.63B | -3.38B | -7.18B | -2.64B | -8.39B | -1.37B | -591.16M | -410.14M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -3.60M | 0 | 0 |
Repayments of term debt | -13.69B | 4.01B | -14.37B | -4.83B | 39.57B | -3.83B | -1.63B | -715.44M | -669.87M |
Cash used in financing activities | -27.79B | 770M | -16.56B | -15.49B | 34.17B | -14.35B | -1.91B | -671.36M | -52.46M |
Net Change In Cash | 3.26B | 1.1B | -892.6M | -2.78B | -3.65B | 5.42B | 1.56B | 943.35M | 1.60B |
Cash at end of period | 8.35B | 5.08B | 5.72B | 6.61B | 7.02B | 14.07B | 7.60B | 6.04B | 5.10B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |